Vimta Labs Ltd

BSE
VIMTALABS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Vimta Labs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
44.16% Gain from 52W Low
22.3
TTM PE Ratio
Below industry Median
30.4
Price to Book Ratio
Below industry Median
3.9
Dividend yield 1yr %
Below industry Median
0.4
TTM PEG Ratio
PEG TTM is negative
-2
RSI
RSI Overbought
72.4
MFI
MFI strongly Overbought
84.4

Vimta Labs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Vimta Labs Ltd shareholding Pattern

Promoter
36.9%
Foreign Institutions
5.2%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
56.4%
Promoter
36.9%
Foreign Institutions
5.1%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
56.4%
Promoter
37%
Foreign Institutions
2.9%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.6%
Promoter
37%
Foreign Institutions
2.7%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.8%
Promoter
37.2%
Foreign Institutions
2.7%
Mutual Funds
1.5%
Domestic Institutions
2.1%
Public
57.9%
Promoter
37.2%
Foreign Institutions
2.2%
Mutual Funds
1.5%
Domestic Institutions
2.1%
Public
58.4%

Vimta Labs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
529.70
10Day EMA
518.70
12Day EMA
515.80
20Day EMA
508.00
26Day EMA
504.60
50Day EMA
497.20
100Day EMA
488.60
200Day EMA
475.90
5Day SMA
523.70
10Day SMA
517.30
20Day SMA
501.40
30Day SMA
496.60
50Day SMA
493.70
100Day SMA
489.00
150Day SMA
473.40
200Day SMA
475.30
Delivery & Volume
Resistance & Support
557.22
Pivot
Resistance
First Resistance
604.43
Second Resistance
646.22
Third Resistance
693.43
Support
First Support
515.43
Second support
468.22
Third Support
426.43
Relative Strength Index
72.43
Money Flow Index
84.45
MACD
11.17
MACD Signal
6.24
Average True Range
25.10
Average Directional Index
17.08
Rate of Change (21)
11.97
Rate of Change (125)
25.14
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Sastasundar Ventures Ltd.
1057.68
252
506.35
Take Solutions Ltd.
302.23
16.99
35.78
Thyrocare Technologies Ltd.
3401.15
511
722
Krsnaa Diagnostics Ltd.
2164.87
448.7
788.6
Medi Assist Healthcare Services Ltd.
3805.46
430.15
605.15
Yash Optics & Lens Ltd.
-
-
-

Vimta Labs Ltd Company background

Founded in: 1990
Managing director: Harita Vasireddi
Vimta Labs Ltd., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and nonGLP), clinical research, central lab, and cGMP as well as nonGMP analytical services for pharmaceutical and biopharmaceutical companies Preclinical research and testing services for medical device companies Contract research and testing for Agroscience companies Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil gas, mining etc. The Company was awarded ISO 9002 Certification under ISO/IEC Guide25 as Certified Competent Laboratory and Quality Endorsed Company by Standards Australia Quality Assurance Services Pty. Ltd in 1994.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company begun to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.The Company is now expanding its operations by five times of its existing capacities at S P Biotech Park, Genome Valley, Turkapally Village, Shamirpet Mandal, Ranga Reddy Dist. The project is expected to commence from September 2005.During the year 200607, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.
Read More

Vimta Labs Ltd FAQs

The past 1-year return of Vimta Labs Ltd [VIMTALABS] share was 19.84. The Vimta Labs Ltd [VIMTALABS] share hit a 1-year low of Rs. 390.6 and a 1-year high of Rs. 621.4.

The Mutual Fund Shareholding was 1.49% at the end of .

You can easily buy Vimta Labs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -